These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 2379386)

  • 1. Inactivation of heparin during extracorporeal circulation in infants.
    Green TP; Isham-Schopf B; Irmiter RJ; Smith C; Uden DL; Steinhorn RH
    Clin Pharmacol Ther; 1990 Aug; 48(2):148-54. PubMed ID: 2379386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conversion From Activated Clotting Time to Anti-Xa Heparin Activity Assay for Heparin Monitoring During Extracorporeal Membrane Oxygenation.
    Figueroa Villalba CA; Brogan TV; McMullan DM; Yalon L; Jordan DI; Chandler WL
    Crit Care Med; 2020 Dec; 48(12):e1179-e1184. PubMed ID: 33009103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activated partial thromboplastin time is a better trending tool in pediatric extracorporeal membrane oxygenation.
    Maul TM; Wolff EL; Kuch BA; Rosendorff A; Morell VO; Wearden PD
    Pediatr Crit Care Med; 2012 Nov; 13(6):e363-71. PubMed ID: 22940857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective heparinization of the extracorporeal membrane oxygenation circuit using continuous infusions of protamine and heparin in a short-term pig model.
    Dickey LA; Butler TJ; Bergmann TM; Bates ME; Null DM
    Perfusion; 1994; 9(5):327-33. PubMed ID: 7833540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Do we need heparin coating for extracorporeal membrane oxygenation? New concepts and controversial positions about coating surfaces of extracorporeal circuits.
    Silvetti S; Koster A; Pappalardo F
    Artif Organs; 2015 Feb; 39(2):176-9. PubMed ID: 25041628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Whole blood activated clotting time in infants during extracorporeal membrane oxygenation.
    Green TP; Isham-Schopf B; Steinhorn RH; Smith C; Irmiter RJ
    Crit Care Med; 1990 May; 18(5):494-8. PubMed ID: 2328593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-factor Xa assay is a superior correlate of heparin dose than activated partial thromboplastin time or activated clotting time in pediatric extracorporeal membrane oxygenation*.
    Liveris A; Bello RA; Friedmann P; Duffy MA; Manwani D; Killinger JS; Rodriquez D; Weinstein S
    Pediatr Crit Care Med; 2014 Feb; 15(2):e72-9. PubMed ID: 24335992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Venovenous Extracorporeal Membrane Oxygenation With Prophylactic Subcutaneous Anticoagulation Only: An Observational Study in More Than 60 Patients.
    Krueger K; Schmutz A; Zieger B; Kalbhenn J
    Artif Organs; 2017 Feb; 41(2):186-192. PubMed ID: 27256966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ex vivo testing of heparin-coated extracorporeal circuits: bovine experiments.
    Weerwind PW; van der Veen FH; Lindhout T; de Jong DS; Cahalan PT
    Int J Artif Organs; 1998 May; 21(5):291-8. PubMed ID: 9684912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Challenges with Navigating the Precarious Hemostatic Balance during Extracorporeal Life Support: Implications for Coagulation and Transfusion Management.
    Andrews J; Winkler AM
    Transfus Med Rev; 2016 Oct; 30(4):223-9. PubMed ID: 27543261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of Duraflo II heparin coating in prolonged extracorporeal membrane oxygenation.
    Toomasian JM; Hsu LC; Hirschl RB; Heiss KF; Hultquist KA; Bartlett RH
    ASAIO Trans; 1988; 34(3):410-4. PubMed ID: 3196539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticoagulation management associated with extracorporeal circulation.
    Sniecinski RM; Levy JH
    Best Pract Res Clin Anaesthesiol; 2015 Jun; 29(2):189-202. PubMed ID: 26060030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is heparin necessary for extracorporeal circulation?
    Whittlesey GC; Kundu SK; Salley SO; Nowlen TT; Klein MD
    ASAIO Trans; 1988; 34(3):823-6. PubMed ID: 3143388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticoagulation and pediatric extracorporeal membrane oxygenation: impact of activated clotting time and heparin dose on survival.
    Baird CW; Zurakowski D; Robinson B; Gandhi S; Burdis-Koch L; Tamblyn J; Munoz R; Fortich K; Pigula FA
    Ann Thorac Surg; 2007 Mar; 83(3):912-9; discussion 919-20. PubMed ID: 17307433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An ex vivo evaluation of blood coagulation and thromboresistance of two extracorporeal circuit coatings with reduced and full heparin dose.
    Teligui L; Dalmayrac E; Mabilleau G; Macchi L; Godon A; Corbeau JJ; Denommé AS; Bouquet E; Boer C; Baufreton C
    Interact Cardiovasc Thorac Surg; 2014 Jun; 18(6):763-9. PubMed ID: 24632424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discordance between ROTEM® clotting time and conventional tests during unfractionated heparin-based anticoagulation in intensive care patients on extracorporeal membrane oxygenation.
    Prakash S; Wiersema UF; Bihari S; Roxby D
    Anaesth Intensive Care; 2016 Jan; 44(1):85-92. PubMed ID: 26673593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlations between activated clotting time values and heparin concentration measurements in young infants undergoing cardiopulmonary bypass.
    Guzzetta NA; Monitz HG; Fernandez JD; Fazlollah TM; Knezevic A; Miller BE
    Anesth Analg; 2010 Jul; 111(1):173-9. PubMed ID: 20519414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-xa directed protocol for anticoagulation management in children supported with extracorporeal membrane oxygenation.
    O'Meara LC; Alten JA; Goldberg KG; Timpa JG; Phillips J; Laney D; Borasino S
    ASAIO J; 2015; 61(3):339-44. PubMed ID: 25710768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term extracorporeal circulation management: the role of low- and high-range heparin ACT tests.
    Herbst D; Najm HK; Jha KN
    J Extra Corpor Technol; 2008 Dec; 40(4):271-4. PubMed ID: 19192757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversal of protamine of the prolonged response to intrapulmonary heparin.
    Wright CJ; Mahadoo J; Jaques LB
    Can J Surg; 1981 Mar; 24(2):130-2. PubMed ID: 7225967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.